Navigation Links
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Date:7/12/2010

d on the neurointerventional market, is a leader in enhanced bioactive coils and a pioneer in the development of new technologies to improve the treatment of ischemic stroke and aneurysms.  The combined business of Codman and Micrus Endovascular will provide a strong suite of solutions for hemorrhagic stroke, with many promising products in development for ischemic stroke. 

"The merger represents an important strategic move in the neuro device space for us and a significant step forward in the delivery of technologies for the prevention and treatment of stroke," said Michael Mahoney, Company Group Chairman for the DePuy Family of Companies.  "Together, Codman and Micrus Endovascular will offer clinicians and their patients a full range of stroke treatments and the potential to impact the condition in ways that could not be realized by either company alone."

"Stroke is a significant cause of death and disability around the world.  At Micrus Endovascular, we are dedicated to developing innovative approaches to treating stroke and improving the outcomes of people impacted by this condition," said John Kilcoyne, Chairman and CEO, Micrus Endovascular.  "By joining forces with Codman & Shurtleff, we believe we could have an even greater impact on treating this condition that accounts for one out of 18 deaths in the U.S."

According to the National Stroke Association, stroke is the third most common cause of death and the leading cause of serious, long-term adult disability in the U.S.   Each year, approximately 795,000 people in the U.S. experience a stroke.  The majority of victims (87%) have an ischemic stroke, which occurs when arteries are blocked by blood clots or other deposits or narrowed due to atherosclerosis; others experience a hemorrhagic stroke, which occurs when a
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
2. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
3. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
4. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
5. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
6. EF Johnson Technologies Announces Third Quarter Results
7. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
8. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
9. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
10. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
11. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Berger & Montague, P.C., a full-spectrum class ... one of the largest and most successful whistleblower ... Faruqi, LLP in settling three separate but related ... Cephalon, Inc., and Biogen, Inc., for a total ... agreements, AstraZeneca will pay the largest sum, $46.5 ...
(Date:7/7/2015)... July 7, 2015 A power morcellator lawsuit ... been settled for an undisclosed amount, Bernstein Liebhard LLP ... in March 2014 in the U.S. District Court, Eastern ... of a widower whose wife had died in February ... hysterectomy that involved the use of a power morcellator. ...
(Date:7/7/2015)... Juli 2015 Sequent Medical, ein ... Entwicklung innovativer Geräte für die Behandlung neurovaskulärer ... von R. Michael Kleine in den ... verfügt über eine mehr als 25-jährige Erfahrung ... hat verschiedene globale biomedizinische Unternehmen erfolgreich geleitet ...
Breaking Medicine Technology:AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3
... a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: ... of vaccines against HPV, anthrax and plague ... The,studies were conducted by the Fraunhofer USA ... Organization led by Dr.,Vidadi Yusibov, through which ...
... Profile and Excellent,Pharmacokinetic Properties -, RESEARCH TRIANGLE PARK, ... a clinical stage company developing and,commercializing innovative treatments ... top-line results from a Phase I,clinical trial of ... and anxiety. In this study, Tyrima was safe ...
Cached Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the ... and CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing ... which have proven to simplify the on-premises deployment of unified remote access and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health ... Excelimmune, Inc. to access its antibody combination therapy (ACT) technology platform. The ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... experience for its patient community using its IDF ePHR, an electronic personal health ... immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... , FRIDAY, Nov. 5 (HealthDay News) -- People undergoing cancer ... possible and avoid exertion, to save all their strength to ... physicians and researchers now say that people who remain physically ... to beat cancer. The positive evidence for exercise during ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Falls from tree ... an Ohio State University study. Researchers analyzed 130 hunting-related ... found that 50 percent of injuries were caused by falls, ... Among the other findings: , Gunshot wounds accounted ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Over ... inflammatory kidney disorder known as lupus nephritis have vastly improved, ... with lupus nephritis, which is a complication that can occur ... can now expect a better quality of life, without many ...
... sent to physicians the moment they ordered a blood ... that is often false-positive for the elderly, according to a ... of Managed Care . The D-dimer test, combined ... of deep vein thrombosis (blood clots in veins, otherwise known ...
... Nov. 5 (HealthDay News) -- New genetic mapping of ... a particular gene mutation are particularly well-skilled in the ... between a specific variation of the so-called "PCSK6 gene" ... hard evidence to suggest that there could be an ...
... DC A large national study finds that screening current ... deaths from lung cancers by 20 percent. One potential ... up tumors at an early stage. The study was ... the country including Georgetown Lombardi Comprehensive Cancer Center, a part ...
Cached Medicine News:Health News:To Best Fight Cancer, New Guidelines Urge Exercise 2Health News:To Best Fight Cancer, New Guidelines Urge Exercise 3Health News:To Best Fight Cancer, New Guidelines Urge Exercise 4Health News:Lupus Kidney Disorder Treatment Improved Over Decade: Review 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 3Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 3
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
250L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: